Prostate cancer frailty study aims to improve care for older men
NCT ID NCT07605936
First seen Jun 27, 2026 ยท Last updated Jun 27, 2026
Summary
This study follows 80 men aged 65 and older with prostate cancer in Ireland. Researchers will measure frailty, daily functioning, and quality of life over 12 months. The goal is to see how well current frailty screening tools predict health outcomes, helping doctors tailor care for older patients.
What this could mean
Our plain-language read of the trial. This is informational only โ not medical advice or a prediction.
- What this could lead to
- If successful, this study could help doctors better identify frail prostate cancer patients who need extra support.
- What could go wrong
- This is an observational study, not a treatment trial. It will not directly improve health, and results may not apply to all patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FRAILTY AT OLDER ADULTS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University Hospital Limerick
RECRUITINGLimerick, Munster, V94 F858, Ireland
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new tracer light up hidden prostate cancer?
- Could deep breaths before surgery ward off Post-Op confusion?
- A second look: MRI screening may spot hidden prostate cancers
- Can precision protons spare the bowel in prostate cancer?
- AI coaches doctors on cancer risk talks
- Can an immune booster make hormone therapy work better against prostate cancer?